Contineum Therapeutics (CTNM)'s 30-day implied volatility (IV30) was 77.6% at the close on October 23, 2026, down from 90.6% the day before, against a 52-week range of 55.0% to 165.1%. Its 20-day historical volatility was 103.0%.
Data as of October 23, 2026.